Announce Date | 07/31/2025 |
EPS Normalized Actual | $1.81 (Beat by $0.04) |
EPS GAAP Actual | $1.81 (Beat by $0.04) |
Revenue Actual | $3.262B |
Revenue Surprise | Beat by $3262M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.64214 |
EPS GAAP Estimate | $1.64214 |
Revenue Estimate | $2.432658385B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 10.6 | 14.86 | 10.25065 | 10.99329 | 1 |
Dec 2028 | 9.3 | 16.94 | 9.02291 | 9.55722 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.49 | 1.49 | 3.262B | 11.19% | 3262M |
FQ1 2025 (Mar 2025) | 1.39 | 1.39 | 3.229B | 15.42% | 3229M |
FQ4 2024 (Dec 2024) | 1.22 | 1.22 | 3.03B | 12.01% | 3030M |
FQ3 2024 (Sep 2024) | 1.14 | 1.14 | 3.033B | 19.91% | 3033M |
FQ2 2024 (Jun 2024) | 1.1 | 1.1 | 2.897B | 19.36% | 2897M |
FQ1 2024 (Mar 2024) | 1.34 | 1.34 | 2.731B | 9.48% | 2731M |
FQ4 2023 (Dec 2023) | 0.64 | 0.64 | 2.666B | -261.44% | 2666M |
FQ3 2023 (Sep 2023) | 0.96 | 0.96 | 2.429B | 1.73% | 2429M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.64214
Consensus Revenue Estimates
2.432658385B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.35 | -- | 2.35 | 2.35 | 5 |
FQ3 2027 (Sep 2027) | 2.33 | -- | 2.33 | 2.33 | 5 |
FQ2 2027 (Jun 2027) | 2.22 | -- | 2.22 | 2.22 | 5 |
FQ1 2027 (Mar 2027) | 2.14 | -- | 2.14 | 2.14 | 5 |
FQ4 2026 (Oct 2026) | 1.865 | -- | 1.79893 | 1.90702 | 4 |
FQ3 2026 (Jul 2026) | 1.835 | -- | 1.76999 | 1.87634 | 4 |
FQ2 2026 (Jun 2026) | 1.83 | 18.58 | 1.73822 | 2.06623 | 11 |
FQ1 2026 (Mar 2026) | 1.82 | 23.63 | 1.72872 | 2.05494 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.94B | -- | 2.94B | 2.94B | 7 |
FQ3 2027 (Sep 2027) | 2.93B | -- | 2.93B | 2.93B | 4 |
FQ2 2027 (Jun 2027) | 2.84B | -- | 2.84B | 2.84B | 4 |
FQ1 2027 (Mar 2027) | 2.78B | -- | 2.78B | 2.78B | 7 |
FQ4 2026 (Oct 2026) | 2.64B | -- | 2.56B | 2.68B | 4 |
FQ3 2026 (Jul 2026) | 2.6B | -- | 2.53B | 2.64B | 6 |
FQ2 2026 (Jun 2026) | 9.33B | 65.04 | 8.97B | 10.26B | 5 |
FQ1 2026 (Mar 2026) | 8.66B | 62.73 | 8.33B | 9.52B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.49 | 1.49 | 100% | |
FQ1 2025 (Mar 2025) | 1.39 | 1.39 | 100% | |
FQ4 2024 (Dec 2024) | 1.22 | 1.22 | 100% | |
FQ3 2024 (Sep 2024) | 1.14 | 1.14 | 100% | |
FQ2 2024 (Jun 2024) | 1.1 | 1.1 | 100% | |
FQ1 2024 (Mar 2024) | 1.34 | 1.34 | 100% | |
FQ4 2023 (Dec 2023) | 0.64 | 0.64 | 100% | |
FQ3 2023 (Sep 2023) | 0.96 | 0.96 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $3.26B | $3262M | 100% |
FQ1 2025 (Mar 2025) | $0B | $3.23B | $3229M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.03B | $3030M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.03B | $3033M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.9B | $2897M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.73B | $2731M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.67B | $2666M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.43B | $2429M | 100% |